Industry: Medical Devices & Consumables
Published Date: 2024-01-10
Pages: 82 Pages
Report ld: 3012023
Request Sample
Customized Report
Injectable Implant Urinary Incontinence Device Market Size(US$)

CAGR 2024-2030
5.9%
Market Size,2030
USD 166.4
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 112 million in 2023 and is forecast to a readjusted size of US$ 166.4 million by 2030 with a CAGR of 5.9% during the forecast period 2024-2030
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Injectable Implant Urinary Incontinence Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Injectable Implant Urinary Incontinence Device by region & country, by Type, and by Application.
The Injectable Implant Urinary Incontinence Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Implant Urinary Incontinence Device.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Injectable Implant Urinary Incontinence Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Injectable Implant Urinary Incontinence Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Injectable Implant Urinary Incontinence Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Injectable Implant Urinary Incontinence Device Product Introduction
1.2 Global Injectable Implant Urinary Incontinence Device Market Size Forecast
1.2.1 Global Injectable Implant Urinary Incontinence Device Sales Value (2019-2030)
1.2.2 Global Injectable Implant Urinary Incontinence Device Sales Volume (2019-2030)
1.2.3 Global Injectable Implant Urinary Incontinence Device Sales Price (2019-2030)
1.3 Injectable Implant Urinary Incontinence Device Market Trends & Drivers
1.3.1 Injectable Implant Urinary Incontinence Device Industry Trends
1.3.2 Injectable Implant Urinary Incontinence Device Market Drivers & Opportunity
1.3.3 Injectable Implant Urinary Incontinence Device Market Challenges
1.3.4 Injectable Implant Urinary Incontinence Device Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Injectable Implant Urinary Incontinence Device Players Revenue Ranking (2023)
2.2 Global Injectable Implant Urinary Incontinence Device Revenue by Company (2019-2024)
2.3 Global Injectable Implant Urinary Incontinence Device Players Sales Volume Ranking (2023)
2.4 Global Injectable Implant Urinary Incontinence Device Sales Volume by Company Players (2019-2024)
2.5 Global Injectable Implant Urinary Incontinence Device Average Price by Company (2019-2024)
2.6 Key Manufacturers Injectable Implant Urinary Incontinence Device Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Injectable Implant Urinary Incontinence Device Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Injectable Implant Urinary Incontinence Device
2.9 Injectable Implant Urinary Incontinence Device Market Competitive Analysis
2.9.1 Injectable Implant Urinary Incontinence Device Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Injectable Implant Urinary Incontinence Device Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Implant Urinary Incontinence Device as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Stress Incontinence
3.1.2 Urge Incontinence
3.1.3 Overflow Incontinence
3.1.4 Functional Incontinence
3.1.5 Others
3.2 Global Injectable Implant Urinary Incontinence Device Sales Value by Type
3.2.1 Global Injectable Implant Urinary Incontinence Device Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Injectable Implant Urinary Incontinence Device Sales Value, by Type (2019-2030)
3.2.3 Global Injectable Implant Urinary Incontinence Device Sales Value, by Type (%) (2019-2030)
3.3 Global Injectable Implant Urinary Incontinence Device Sales Volume by Type
3.3.1 Global Injectable Implant Urinary Incontinence Device Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Injectable Implant Urinary Incontinence Device Sales Volume, by Type (2019-2030)
3.3.3 Global Injectable Implant Urinary Incontinence Device Sales Volume, by Type (%) (2019-2030)
3.4 Global Injectable Implant Urinary Incontinence Device Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 Ambulatory Surgery Centres
4.1.3 Others
4.2 Global Injectable Implant Urinary Incontinence Device Sales Value by Application
4.2.1 Global Injectable Implant Urinary Incontinence Device Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Injectable Implant Urinary Incontinence Device Sales Value, by Application (2019-2030)
4.2.3 Global Injectable Implant Urinary Incontinence Device Sales Value, by Application (%) (2019-2030)
4.3 Global Injectable Implant Urinary Incontinence Device Sales Volume by Application
4.3.1 Global Injectable Implant Urinary Incontinence Device Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Injectable Implant Urinary Incontinence Device Sales Volume, by Application (2019-2030)
4.3.3 Global Injectable Implant Urinary Incontinence Device Sales Volume, by Application (%) (2019-2030)
4.4 Global Injectable Implant Urinary Incontinence Device Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Injectable Implant Urinary Incontinence Device Sales Value by Region
5.1.1 Global Injectable Implant Urinary Incontinence Device Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Injectable Implant Urinary Incontinence Device Sales Value by Region (2019-2024)
5.1.3 Global Injectable Implant Urinary Incontinence Device Sales Value by Region (2025-2030)
5.1.4 Global Injectable Implant Urinary Incontinence Device Sales Value by Region (%), (2019-2030)
5.2 Global Injectable Implant Urinary Incontinence Device Sales Volume by Region
5.2.1 Global Injectable Implant Urinary Incontinence Device Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Injectable Implant Urinary Incontinence Device Sales Volume by Region (2019-2024)
5.2.3 Global Injectable Implant Urinary Incontinence Device Sales Volume by Region (2025-2030)
5.2.4 Global Injectable Implant Urinary Incontinence Device Sales Volume by Region (%), (2019-2030)
5.3 Global Injectable Implant Urinary Incontinence Device Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Injectable Implant Urinary Incontinence Device Sales Value, 2019-2030
5.4.2 North America Injectable Implant Urinary Incontinence Device Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Injectable Implant Urinary Incontinence Device Sales Value, 2019-2030
5.5.2 Europe Injectable Implant Urinary Incontinence Device Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Injectable Implant Urinary Incontinence Device Sales Value, 2019-2030
5.6.2 Asia Pacific Injectable Implant Urinary Incontinence Device Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Injectable Implant Urinary Incontinence Device Sales Value, 2019-2030
5.7.2 South America Injectable Implant Urinary Incontinence Device Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Injectable Implant Urinary Incontinence Device Sales Value, 2019-2030
5.8.2 Middle East & Africa Injectable Implant Urinary Incontinence Device Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Value
6.2.1 Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Value, 2019-2030
6.2.2 Key Countries/Regions Injectable Implant Urinary Incontinence Device Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Injectable Implant Urinary Incontinence Device Sales Value, 2019-2030
6.3.2 United States Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Injectable Implant Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Injectable Implant Urinary Incontinence Device Sales Value, 2019-2030
6.4.2 Europe Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Injectable Implant Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Injectable Implant Urinary Incontinence Device Sales Value, 2019-2030
6.5.2 China Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.5.3 China Injectable Implant Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Injectable Implant Urinary Incontinence Device Sales Value, 2019-2030
6.6.2 Japan Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Injectable Implant Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Injectable Implant Urinary Incontinence Device Sales Value, 2019-2030
6.7.2 South Korea Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Injectable Implant Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Injectable Implant Urinary Incontinence Device Sales Value, 2019-2030
6.8.2 Southeast Asia Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Injectable Implant Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Injectable Implant Urinary Incontinence Device Sales Value, 2019-2030
6.9.2 India Injectable Implant Urinary Incontinence Device Sales Value by Type (%), 2023 VS 2030
6.9.3 India Injectable Implant Urinary Incontinence Device Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Boston Scientific
7.1.1 Boston Scientific Company Information
7.1.2 Boston Scientific Introduction and Business Overview
7.1.3 Boston Scientific Injectable Implant Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Boston Scientific Injectable Implant Urinary Incontinence Device Product Offerings
7.1.5 Boston Scientific Recent Development
7.2 Laborie Medical
7.2.1 Laborie Medical Company Information
7.2.2 Laborie Medical Introduction and Business Overview
7.2.3 Laborie Medical Injectable Implant Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Laborie Medical Injectable Implant Urinary Incontinence Device Product Offerings
7.2.5 Laborie Medical Recent Development
7.3 Urogyn B.V.
7.3.1 Urogyn B.V. Company Information
7.3.2 Urogyn B.V. Introduction and Business Overview
7.3.3 Urogyn B.V. Injectable Implant Urinary Incontinence Device Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Urogyn B.V. Injectable Implant Urinary Incontinence Device Product Offerings
7.3.5 Urogyn B.V. Recent Development
8 Industry Chain Analysis
8.1 Injectable Implant Urinary Incontinence Device Industrial Chain
8.2 Injectable Implant Urinary Incontinence Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Injectable Implant Urinary Incontinence Device Sales Model
8.5.2 Sales Channel
8.5.3 Injectable Implant Urinary Incontinence Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 131 million in 2025 and is projected to reach US$ 194 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 121
USD 3950.00
(Single User License)
The global Injectable Implant Urinary Incontinence Device market was valued at US$ 131 million in 2025 and is anticipated to reach US$ 194 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 104
USD 2900.00
(Single User License)
The global Injectable Implant Urinary Incontinence Device market size was US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 67
USD 4250.00
(Single User License)
The global Injectable Implant Urinary Incontinence Device market is projected to grow from US$ 124 million in 2024 to US$ 185 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 118
USD 4900.00
(Single User License)
The global market for Injectable Implant Urinary Incontinence Device was valued at US$ 124 million in the year 2024 and is projected to reach a revised size of US$ 185 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-01-16
Pages: 67
USD 2900.00
(Single User License)
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 82
USD 3950.00
(Single User License)
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-04-12
Pages: 75
USD 4900.00
(Single User License)
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published Date: 2024-01-17
Pages: 74
USD 2900.00
(Single User License)
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 131 million in 2025 and is projected to reach US$ 194 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-06-16
Pages: 121
The global Injectable Implant Urinary Incontinence Device market was valued at US$ 131 million in 2025 and is anticipated to reach US$ 194 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-04-17
Pages: 104
The global Injectable Implant Urinary Incontinence Device market size was US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 67
The global Injectable Implant Urinary Incontinence Device market is projected to grow from US$ 124 million in 2024 to US$ 185 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 118
The global market for Injectable Implant Urinary Incontinence Device was valued at US$ 124 million in the year 2024 and is projected to reach a revised size of US$ 185 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-01-16
Pages: 67
The global market for Injectable Implant Urinary Incontinence Device was estimated to be worth US$ 124 million in 2024 and is forecast to a readjusted size of US$ 185 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 82
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-04-12
Pages: 75
Injectable implants are injections of material into the urethra to help control urine leakage (urinary incontinence) caused by a weak urinary sphincter. Injectable therapy using bulking agents composed of synthetic materials, bovine collagen, or autologous substances augment the urethral wall and increase urethral resistance to urinary flow. The injection of bulking agents to treat a dysfunctional urethra is a minimally invasive method of correcting intrinsic sphincteric deficiency that results in stress urinary incontinence but is being performed less frequently in current practice.
Published: 2024-01-17
Pages: 74
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now